Professor
Biochemistry, Cancer Biology, Neuroscience, Pharmacology
School of Medicine
(615) 327-6749 | lstewart@mmc.edu | Biosketch
Meharry Summer Undergraduate Research Experiences in Cancer Program (R25CA21422001), NIH
Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.
Emuejevoke Olokpa, Patrice E Moss, LaMonica V Stewart
The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.
Emuejevoke Olokpa, Adrienne Bolden, LaMonica V Stewart
The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.
Adrienne Bolden, Lynikka Bernard, Danielle Jones, Tunde Akinyeke, Lamonica V Stewart
Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
Tunde O Akinyeke, LaMonica V Stewart
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Patrice E Moss, Besstina E Lyles, LaMonica V Stewart
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Besstina E Lyles, Tunde O Akinyeke, Patrice E Moss, LaMonica V Stewart
Keywords
prostate cancer, ppar gamma, androgen receptor, intracellular signaling, cell proliferation